The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
sarepta therapeutics | 471 |
avi biopharma | 170 |
serepta therapeutics | 4 |
isis pharmaceuticals | 4 |
ercole biotech | 2 |
ionis pharmaceuticals | 1 |
sage therapeutics | 1 |
avi biopharma | 25 |
isis pharmaceuticals | 1 |
ercole biotech | 1 |
sarepta therapeutics | 1 |
sarepta therapeutics | 119 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
multiple exon skipping compositions for dmd | 51 | 2008 |
oligonucleotide analogues targeting human lmna | 35 | 2011 |
functionally-modified oligonucleotides and subunits thereof | 28 | 2011 |
oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | 27 | 2010 |
method of synthesis of morpholino oligomers | 26 | 2007 |
antisense antiviral compound and method for treating influenza viral infection | 24 | 2009 |
exon skipping compositions for treating muscular dystrophy | 23 | 2013 |
boronic acid conjugates of oligonucleotide analogues | 21 | 2012 |
oligonucleotide analogs having cationic intersubunit linkages | 21 | 2006 |
antisense antiviral compounds and methods for treating a filovirus infection | 19 | 2010 |